Code
3G015612
Duration
01 January 2012 → 31 December 2017
Funding
Research Foundation - Flanders (FWO)
Promotor
Research disciplines
-
Medical and health sciences
- Gastro-enterology and hepatology
- Morphological sciences
- Oncology
- Gastro-enterology and hepatology
- Morphological sciences
- Oncology
- Gastro-enterology and hepatology
- Morphological sciences
- Oncology
Keywords
hepatocellular carcinoma
chemoresistance
angiogenesis
ER stress
Project description
Systemic chemotherapy with classical cytotoxic drugs in hepatocellular carcinoma yields low objective response rates due to chemoresistance. It is well known that as wel hypoxia as ER stress could be the cause of chemoresitance. The efficay and safety of anti-PlGF and farnesylthiosalicylic acidmay consitute a novel approach for cancer treatment. This will be evaluated in a HCC mouse model.